Tianjin TEDA Biomedical Engineering Co Ltd (HKSE:08189) Share Price

Company Profile

Business description
Tianjin TEDA Biomedical Engineering Co Ltd is engaged in the research, development, and commercialization of biological compound fertilizers, providing elderly and health care services. It operates in two segments namely; biological compound fertilizers products, and elderly care and health care services. The company generates a majority of its revenue from the Fertilisers products segment which is engaged in manufacturing and selling biological compound fertiliser products, including active fertiliser, mixture with nitrogen, phosphorus, and potassium with various formulas, providing warehousing services, and processing and licensing of the fertiliser products. The People's Republic of China is the primary geographical market for the company.
Contact
No. 80, The 4th Avenue
9th Floor, Block A2, Tianda Hi-Tech Park
TEDA Tianjin
Tianjin
CHN
T: +86 2259816900
http://www.bioteda.com
Sector
Basic Materials
Stock type
Cyclical
Industry
Agricultural Inputs
Fiscal Year End
31 December 2026
Employees
273

Recommended

International expansion is a distraction from valuable local business.

Roy Van Keulen | 14 May 2026

The chipmaker’s IPO priced at $185, well above its initial range, and opened trading at an eye-popping $350.

Jacob Robbins | 14 May 2026

How the most traded shares in April stack up against our analysts views.

Tyger Fitzpatrick | 14 May 2026

Index	Last price	Change	% Change
All Ordinaries	8,870.60	46.70	-0.52%
CAC 40	7,985.96	96.31	-1.19%
DAX 40	24,071.02	385.24	-1.58%
Dow JONES (US)	50,063.46	370.26	0.75%
FTSE 100	10,241.39	131.54	-1.27%
HKSE	25,962.73	426.31	-1.62%
NASDAQ	26,635.22	232.88	0.88%
Nikkei 225	61,409.29	1,244.76	-1.99%
NZX 50 Index	12,965.01	60.06	-0.46%
S&P 500	7,501.24	56.99	0.77%
S&P/ASX 200	8,630.80	42.70	-0.49%
SSE Composite Index	4,135.39	42.53	-1.02%